Correlation Between Quoin Pharmaceuticals and Exela Technologies

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Exela Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Exela Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Exela Technologies Preferred, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Exela Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Exela Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Exela Technologies.

Diversification Opportunities for Quoin Pharmaceuticals and Exela Technologies

0.0

Correlation Coefficient

Quoin Pharmaceuticals  Exela Technologies

Pay attention - limited upside

The 3 months correlation between Quoin and Exela is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Exela Technologies Preferred in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exela Technologies and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Exela Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exela Technologies has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Exela Technologies go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Exela Technologies

If you would invest (100.00) in Exela Technologies Preferred on December 28, 2024 and sell it today you would earn a total of  100.00  from holding Exela Technologies Preferred or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Exela Technologies Preferred

Quoin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Exela Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Exela Technologies Preferred has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Exela Technologies is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Quoin Pharmaceuticals and Exela Technologies

The main advantage of trading using opposite Quoin Pharmaceuticals and Exela Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Exela Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exela Technologies will offset losses from the drop in Exela Technologies' long position.

The idea behind Quoin Pharmaceuticals Ltd and Exela Technologies Preferred pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.